-
Geptanolimab (CBT-501) is a programmed death-1 (PD-1) monoclonal antibody. Geptanolimab can be used in research forsolid tumor research. -
MC2590 is a potent pyridine-containing HDAC inhibitor and modulates pro- and anti-apoptotic microRNAs toward apoptosis induction. -
YX-2-107 is a PROTAC that selectively degrades CDK6. -
Mogamulizumab is an Anti-CCR4 monoclonal antibody. It enhances antibody-dependent cellular cytotoxicity and is effective against leukemia. -
Spiruchostatin A is a potent HDAC inhibitor that can induce apoptosis and has anticancer activity uesd for leukemia studies. -
Abexinostat, a potent and broad-spectrum inhibitor of histone deacetylases, can be used for the research of cancer. -
BNS-22 is a potent and selective inhibitor of TOP2α and TOP2β that exhibits anti-proliferative activities. -
Seliciclib, a potent, selective and orally active CDKs inhibitor, preferentially inhibits CDK2, CDK7 and CDK9. -
Chelerythrine is a potent inhibitor pf protein kinase C with anti-cancer activity. -
HM43239 is a potent, selective, and orally active FLT3 inhibitor and shows effectiveness in AML with FLT3 mutations.
Categories
Diseases
Others
Archives
- March 2023 (1)
- February 2023 (1)
- January 2023 (1)
- December 2022 (2)
- November 2022 (1)
- August 2022 (1)
- May 2022 (1)
- March 2022 (1)
- February 2022 (1)
- January 2022 (1)
- December 2021 (2)
- November 2021 (1)
- October 2021 (3)
- September 2021 (2)
- August 2021 (1)
- July 2021 (2)
- June 2021 (1)
- May 2021 (1)
- April 2021 (2)
- February 2021 (1)
- January 2021 (1)
- December 2020 (1)
- November 2020 (4)
- September 2020 (1)
- July 2020 (2)
- June 2020 (2)
- May 2020 (1)
- March 2020 (1)
- January 2020 (2)
- December 2019 (2)
- September 2019 (3)
- August 2019 (3)
- July 2019 (2)
- May 2019 (1)
- April 2019 (1)
